| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |